Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 3-Step exercise plan become standard in cancer care?

NCT ID NCT07210905

Knowledge-focused Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This study tests whether a simple 3-step exercise protocol (assess, advise, refer) can be made a standard part of cancer care. Researchers will train clinic staff and track how many eligible patients are screened and referred to a weight management program. About 1,800 cancer survivors who finished treatment within the past five years will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
3-step Assess-Advise-Refer exercise protocol (FitARise)
What this could lead to
If successful, this could make exercise counseling a routine part of cancer care, helping more patients get support to improve their health after treatment.
What could go wrong
This is an implementation study, not a test of a new drug or treatment. It focuses on changing how clinics work, so even if it succeeds, direct patient benefits may take time and may not be seen in all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Cancer patients): * All cancer patients with BMI score\>=23; * Have completed cancer treatment within the past five years; * At least 18 years old; * Are literate in Chinese or English; * Are eligible to attend the intervention program. Exclusion Criteria (Cancer patients): * Patients who have completed cancer treatments for more than five years; * Non-Cantonese, non-Mandarin, non-English speakers. Inclusion Criteria (Clinical staff): \- All clinical, medical or surgical oncologists at the study units during the study period. Exclusion Criteria (Clinical staff): \- No exclusion criterial for staff.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Motor Activity neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Cancer (colon cancer, breast cancer, lymphoma, chronic lymphoma leukemia, multiple myeloma) Exercise

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • KWH Department of Surgery

    RECRUITING

    Hong Kong, Hong Kong

  • PMH Department of Oncology

    RECRUITING

    Hong Kong, Hong Kong

  • PYEH Department of Clinical Oncology

    RECRUITING

    Hong Kong, Hong Kong

  • QMH Department of Clinical Oncology

    RECRUITING

    Hong Kong, Hong Kong

  • QMH Department of Obstetrics and Gynaecology

    RECRUITING

    Hong Kong, Hong Kong

  • QMH Department of Surgery

    RECRUITING

    Hong Kong, Hong Kong

  • TMH Department of clinical oncology

    RECRUITING

    Hong Kong, Hong Kong

  • YCH Surgery Department

    RECRUITING

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.